AKT1 and breast carcinoma: Although the direct evidence for the involvement of Mdm2 in Akt-mediated cancer development is still lacking, Mdm2 S166D/S186D, but not wild-type Mdm2, synergizes with Neu overexpression to promote breast cancer development [76].